The CVAA Link: Winter/Spring 2021

THE CVAA

Newsletter of the Canadian Vascular Access Association

Winter/Spring 2021

Canadian Vascular Access and Infusion Therapy Day January 25, 2021 marked the 5th Annual Canadian Vascular Access & Infusion Therapy Day that was celebrated across the country. This year’s theme was ONE ACCESS: THE RIGHT ONE FROM THE START. We challenged our members and chapters to explore what this means to them and we were so thrilled to see such creative celebrations!

Thank you for celebrating in your region and to all of you who strive to promote best practice every day with your patients!

Toronto The IV Team at the Scarborough Hospital (General and Birchmount sites) is comprised of many CVAA members. Anne Coghlan and her team were proud to celebrate the Canadian Vascular Access & Infusion Therapy Day.

Nova Scotia At the Aberdeen Hospital in New Glasgow, N.S., the commitment to evidence-based practice is demonstrated by the nurse-lead vascular access program. Since its development in 2015, the utilization of latest equipment/technology and application of best practice guidelines (CVAA, Canadian Vascular Access and Infusion Therapy Guidelines © 2019) has led to positive outcomes in that patient population, with 90% requiring IV access. The commitment of the clinician in the evolving specialty of vascular access is demonstrated through national CVAA(c) Certification and continued education.

PEI The team at Prince County Hospital with the PEI CVAA Chapter share how they are celebrating the national day with this flyer, this A-Z tips presentation and this video.

Bermuda Demar Thompson and Alien Guilas-Frias share a video discussing the need for the right access.

Member Rachel Batty hosted a webinar for colleagues and clinicians about the value of guidelines during this COVID pandemic.

Janice Buttle, RN, CVAA(c) and Shawn Parnell, BSc., RN, CVAA(c)

Janice Buttle, RN, CVAA(c) and Chanda MacDonald, BSc., RN, CVAA(c) with their BD Awards

Winter/Spring 2021 | Page 2

President’s Message In a time where everyone is asking “Is it over yet?” I come to you hoping for the same. As the newest president for CVAA, I find myself thinking of my fellow healthcare professionals who are tired and hoping for the light at the end of this tunnel. Please know that we, at CVAA, hope you and your families are safe and able to take care of yourselves. We so greatly value your membership and your time. Time to read the journal, time to read our Friday File emails, time to be a part of all of our great committees and teams. We know that your time is so precious and we appreciate you spending some of it with us. We know that if nothing else, this pandemic has taught us the value of ingenuity, to turn and pivot, and to improve the outcomes for our patients, clients and residents. At CVAA we have also been trying to create new ways to reach out to you, our members, and the reason we exist as an organization.

This year will be our first fully virtual conference and I am really excited to enter this new realm with you all! The conference committee is working closely with an expert virtual event planner company to present some of the same features you have always enjoyed about our conferences, even though we are miles apart.

How great would it be to have materials or devices mailed to you for your Skills Lab Station so that you can participate hands-on in real time?! This is the type of innovation we are working towards to make it the best first virtual conference ever! When I think back to the time when I first considered putting my name forth for consideration for the role of CVAA President, it never occurred to me that I would be doing it in the middle of a global change, unlike anything

most of us have ever experienced before. I come to work every day as a Nurse Educator with the intent to do the best I can for the staff and patients I see. I love a challenge and hope to effect change with my teaching. These are the attributes I humbly bring to you as your president for 2021-2022. I look forward to the evolution of CVAA in this new world and I hope that I provide the leadership you desire for our Canadian Vascular Access Association.

In closing, know that we have never stopped in our mission to move vascular access and infusion therapy to the forefront of healthcare and we appreciate all you do everyday.

Carmen Cernusca, RN, BScN, MScN, CVAA(c) CVAA President

Winter/Spring 2021 | Page 3

WITH A DUAL FORMULATION STERILE SOLUTION AND STERILE APPLICATOR. The new BD ChloraPrep™ Patient Preoperative Skin Preparation has elevated sterility assurance to a higher level, achieving a sterility assurance level (SAL) of 10 –6, the same required for injectable products.1 Other 2% chlorhexidine gluconate (CHG)/alcohol applicators used in hospitals today do not contain sterile solutions, which may put patients at risk of infection.2 Rest assured that you’re putting your patients’ safety first when using this dual formulation of sterile 2% CHG + 70% isopropyl alcohol (IPA) solution packaged in a one-step, single-use sterile applicator. Developed by our unique proprietary sterilization process,1 we have achieved what may have been thought of as impossible.

Discover the difference of overcoming antiseptic contamination. Discover the new BD.

References 1 Degala, et al. United States Patent 9,078,934. July 14, 2015.

2 Chang C, Furlong LA. Microbial stowaways in topical antiseptic products. N Eng J Med. 2012;367(23):2170-2173.

Discover our fully sterile skin prep products at bd.com/SterileSolution BD, the BD Logo and ChloraPrep are trademarks of Becton, Dickinson and Company or its affiliates. © 2020 BD. All rights reserved. 1120/5673

Strategic Plan

The CVAA Board of Directors held our annual weekend meeting virtually this year and were joined once again by Jacqueline Valmont of Valmont & Associates to assist us with our Strategic Planning process. Due to the uncertainty of this coming year due to the COVID-19 pandemic, the CVAA Board developed a one year Strategic Plan that will act as an extension of the 2018–2020 plan. Our current Strategic Priorities: • Generate, Disseminate & Translate Knowledge into Measurable Procedural Competence

• Increase, Diversity, Add Value & Engage Membership • Demonstrate and Advocate for the Value of Our Specialty • “Elevate” the Organization to Support CVAA’s Future Growth If you are interested in getting involved with any Committee or initiatives, we welcome you to contact Melissa Stark at cvaa@cvaa.info for additional information. You can find the full plan here.

Winter/Spring 2021 | Page 5

Report from the NEOCVAA Chapter The 5th Annual Canadian Vascular Access and Infusion Therapy Day was advertised to our members across Northeastern Ontario with the CVAA poster and a challenge to take a quiz for a prize.

Ten vascular access-related questions were sent in a Google survey format to which we received several responses. The tests are being collated and prizes will be awarded—six of our members had 10/10 questions correct! Good work!

We are happy to state that COVID-19 has only had a minimal impact on our chapter activities as our usual format for membership meetings is via telemedicine to reach more than

a dozen communities in our region. The executive made the decision to cancel our in-person CVAA Learning Event (CLE) day booked for September 2020, but instead planned a Teams meeting with education (thanks to Covalon Technologies for an informative presentation) for November, enabling our annual election and AGM. NEOCVAA welcomes three new executive members from across the region to our group: Chantal Miljours (North Bay), Celine Messier (Elliot Lake) and Patrick Belec (Sudbury), as we bid farewell to Sylvie Kozlowskyj, our past administrative executive and Shelley Lacelle our past treasurer. Sylvie was awarded a Lifetime membership in our

chapter in recognition for her 10 years of support of the chapter— an award that NEOCVAA instituted three years ago to honour exemplary contribution to our NEOCVAA chapter.

We are currently settling into new executive roles, including responsibility for the newsletter that is sent three times/year and management of our email account neocvaa@gmail.com.

The next slated activity is our membership meeting booked in February with SterileCare Inc. providing an educational session. Behind the scenes work is happening to try and host a CLE in September 2021 from a virtual platform. Stay tuned!

Stay Safe!

Follow CVAA on Social Media CVAA (and many of our chapters!) can be found on Facebook (Canadian Vascular Access Association), Instagram (@CVAACanada) and Twitter (@CVAACanada). Now more than ever, we are connecting online and we’re working hard to engage frequently on social media. Click on the links below to be taken directly to our page. See you online and thank you for participating!

Winter/Spring 2021 | Page 6

2021 CVAA Conference

The 46th Annual CVAA Conference this year will be going fully virtual! We are working with an excellent team at Redstone Agency to help us pull this off and make it as engaging, educational and exciting as we can! We hope to see many more members attend as there is no travel or

hotel required! Early bird rates apply until March 31, 2021, and as a CVAA member, you get a discounted rate. Everyone who registers before March 31 will receive a physical delegate kit with Skills Lab materials and all sorts of other goodies and giveaways. Don’t delay!

Winter/Spring 2021 | Page 7

The Preliminary Program is available here with scheduled plenary and concurrent sessions, exhibit hall, hands-on Skills Lab stations (yes, handson!) and much more. We hope to see you there!

StatSeal ®

Top questions on Sosido 2020

STANDARDIZE, SIMPLIFY & MINIMIZE post procedure care & maintenance of vascular access sites with StatSeal® topical dressing products.

StatSeal® Disc

Want to know what Canadian vascular access professionals are talking about?

Take a look at the “Top 25” discussions in the CVAA forum in 2020! 2020 was another busy year in the CVAA discussion forum, with 64 questions and 221 answers about important vascular access topics. Check out the 25 most discussed CVAA questions of last year! Have you logged in yet? Free for CVAA members!

Top 25 Questions: Read them here.

StatSeal® Powder

Prevents Oozing & Bleeding Works independently of the clotting cascade to form an occlusive SEAL over site Minimizes Dressing Disruptions Keeps sites dry & intact until the scheduled dressing change Improves Outcomes Shown to reduce infection rates by more than 90% when included in CLABSI reduction strategy1 Integrate StatSeal® Powder & Disc products into your insertion protocols today!

1.705.328.2518

mail@cardiomed.com

StatSeal® is Manufactured by Biolife, LLC MKT-FORM-078.0 [1] Wilder KA, et al. CLABSI Reduction Strategy: A Systematic Central Line Quality Improvement Initiative Integrating Line-Rounding Principles and a Team Approach. Adv Neonatal Care. 2016 Jun;16(3):170-7.

The SEAL is the difference.

Winter/Spring 2021 | Page 8

SoluPrep

™

Brand

Did you hear about the organisms that survived ™ ™ 3M SoluPrep 2% CHG70% IPA Products?

Neither did we.

1

3M™ SoluPrep™ Brand Skin Antiseptics help to reduce bacteria on a patient’s skin, to help diminish the risk of infections.

3M™ SoluPrep™ Brand Skin Antiseptic Products are manufactured following Health Canada’s Good Manufacturing Practices Guide for Drug Products (GUI-0001).1 All 3M Canada drug products released to the market have undergone rigorous quality testing to ensure the products are free from objectionable organisms.

Visit 3M.ca/SoluPrep or contact your 3M sales representative to learn more.

3M™ SoluPrep™ Skin Antiseptic Products are indicated for use as a skin antiseptic prior to invasive procedures and to help reduce bacteria on skin to diminish the risk of infection.

See Warnings, Cautions and Directions for Use at 3M.ca/SkinPrep for information to assist in benefit-risk assessment. Always read the product label before use.

Prepping with confidence.

3M Canada Company Medical Solutions Division 300 Tartan Drive London, ON N5V 4M9 Canada 1-800-364-3577 3M.ca

1

3M has not found an organism that could survive and grow in 3M™ SoluPrep™ 2% CHG 70% IPA Solution. (Based on test organisms identified by Health Canada for professional health care use, using test method EN 13727 and EN 13624 and 3M internal challenge studies using 3M Canada test methods based on current USP and cGMP Health Canada.)

3M and SoluPrep are trademarks of 3M. Used under license in Canada. © 2021, 3M. All rights reserved. 2101-19424 E

2021 Corporate Members A great big thank you once again to our loyal 2021 Corporate Members

Winter/Spring 2021 | Page 10